Rigel Pharmaceuticals Ownership | Who Owns Rigel Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Rigel Pharmaceuticals Ownership Summary


Rigel Pharmaceuticals is owned by 6.50% institutional investors, 2.59% insiders, and 90.92% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 9.09% of RIGL shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.07% of its assets in Rigel Pharmaceuticals shares.

RIGL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRigel Pharmaceuticals6.50%2.59%90.92%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de1.63M9.09%$30.45M
Armistice capital1.60M8.95%$29.97M
Soleus capital management658.14K3.68%$12.33M
Acadian asset management623.00K3.48%$11.66M
Capitolis liquid global markets591.55K3.31%$11.08M
Marshall wace, llp368.95K2.06%$6.91M
Assenagon asset management240.00K1.34%$4.50M
Qube research171.42K0.96%$3.21M
Globeflex capital l p167.51K0.94%$3.14M
Lazard asset management157.00K0.88%$2.94M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Soleus capital management658.14K0.82%$12.33M
Armistice capital1.60M0.52%$29.97M
Globeflex capital l p167.51K0.26%$3.14M
Empire financial management company23.50K0.13%$440.15K
Ubs oconnor104.89K0.10%$1.96M
Jackson creek investment advisors18.05K0.09%$338.00K
Capitolis liquid global markets591.55K0.08%$11.08M
Virtus etf advisers2.21K0.05%$41.49K
Nj state employees deferred compensation plan20.00K0.04%$374.60K
Dynamic technology lab private14.00K0.04%$262.00K

Top Buyers

HolderShares% AssetsChange
Marshall wace, llp368.95K0.01%157.20K
Globeflex capital l p167.51K0.26%115.22K
Lsv asset management95.70K0.00%95.70K
Armistice capital1.60M0.52%84.00K
Acadian asset management623.00K0.02%57.96K

Top Sellers

HolderShares% AssetsChange
Blackrock---14.80M
Morgan stanley---14.44M
Vanguard group---9.37M
Geode capital management---3.79M
State street---3.73M

New Positions

HolderShares% AssetsChangeValue
Lsv asset management95.70K0.00%95.70K$1.79M
Mackenzie financial37.83K0.00%37.83K$708.50K
Arrowstreet capital, limited partnership21.98K0.00%21.98K$411.74K
American century companies16.93K0.00%16.93K$317.19K
Dz bank ag deutsche zentral genossenschafts bank, frankfurt am main9.49K0.00%9.49K$177.73K

Sold Out

HolderChange
Ifp advisors-1.00
Synergy asset management-15.00
Strategic investment solutions, inc. /il-25.00
Srs capital advisors-32.00
Harbour investments-40.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20253-97.60%1,156,951-90.41%60.14%1-98.78%1-95.24%
Dec 31, 2024650.00%1,21265.35%-39369.05%2100.00%--
Sep 30, 20244-55.56%733-94.24%-7854.79%1-50.00%--100.00%
Jun 30, 20249-92.62%12,725-99.99%-0.00%2-96.00%5-87.18%
Mar 31, 20241223.39%111,001,2854.17%631.69%50-9.09%3930.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF548.78K3.07%-
Vanguard Total Stock Mkt Idx Inv548.78K3.07%-
iShares Russell 2000 ETF418.23K2.33%-7.98K
Vanguard Institutional Extnd Mkt Idx Tr276.13K1.54%1.11K
SPDR® S&P Biotech ETF221.81K1.24%5.50K
Fidelity Small Cap Index176.19K0.99%-38.00
Delaware Healthcare I160.00K0.91%-
Macquarie Healthcare I160.00K0.90%-
iShares Russell 2000 Growth ETF153.36K0.85%-
Lazard US Sm Cap Eq WW Dist EUR148.85K0.83%29.23K

Recent Insider Transactions


DateNameRoleActivityValue
Feb 04, 2025Schorno Dean L EVP & Chief Financial OfficerSell$42.60K
Feb 05, 2025Schorno Dean L EVP & Chief Financial OfficerSell$38.02K
Feb 05, 2025Santos David A EVP, Chief Commercial OfficerSell$39.38K
Feb 04, 2025Santos David A EVP, Chief Commercial OfficerSell$44.46K
Feb 04, 2025RODRIGUEZ RAUL R CEO, PresidentSell$103.60K

Insider Transactions Trends


DateBuySell
2025 Q1-8
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1-6

RIGL Ownership FAQ


Who Owns Rigel Pharmaceuticals?

Rigel Pharmaceuticals shareholders are primarily institutional investors at 6.50%, followed by 2.59% insiders and 90.91% retail investors. The average institutional ownership in Rigel Pharmaceuticals's industry, Biotech Stocks , is 64.05%, which Rigel Pharmaceuticals falls below.

Who owns the most shares of Rigel Pharmaceuticals?

Rigel Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (1.63M shares, 9.09%), Armistice capital (1.6M shares, 8.95%), and Soleus capital management (658.14K shares, 3.68%). Together, they hold 21.72% of Rigel Pharmaceuticals’s total shares outstanding.

Does Blackrock own Rigel Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Rigel Pharmaceuticals.

Who is Rigel Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Soleus capital management is Rigel Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.82% of its assets in 658.14K Rigel Pharmaceuticals shares, valued at 12.33M$.

Who is the top mutual fund holder of Rigel Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Rigel Pharmaceuticals shares, with 3.07% of its total shares outstanding invested in 548.78K Rigel Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools